Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126729171 | 12672917 | 1 | I | 201603 | 20160810 | 20160822 | 20160822 | EXP | FR-NOVOPROD-505765 | NOVO NORDISK | 77.00 | YR | E | F | Y | 0.00000 | 20160822 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126729171 | 12672917 | 1 | PS | NovoNorm | REPAGLINIDE | 1 | Unknown | 6 DF, QD | Y | N | UNKNOWN | 20741 | 6 | DF | TABLET | QD | |||
126729171 | 12672917 | 2 | SS | NovoNorm | REPAGLINIDE | 1 | Unknown | 1MG 2 TIMES A DAY AT NOON AND IN EVENING | Y | N | UNKNOWN | 20741 | TABLET | ||||||
126729171 | 12672917 | 3 | SS | STAGID | METFORMIN PAMOATE | 1 | Oral | 3 DF, QD | Y | U | UNKNOWN | 0 | 3 | DF | QD | ||||
126729171 | 12672917 | 4 | SS | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | Oral | 1 DF, QD | Y | U | UNKNOWN | 0 | 1 | DF | QD | ||||
126729171 | 12672917 | 5 | SS | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 1 DF, QD | Y | U | UNKNOWN | 0 | 1 | DF | QD | ||||
126729171 | 12672917 | 6 | C | SIMVASTATINE | SIMVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
126729171 | 12672917 | 7 | C | AVLOCARDYL /00030001/ | PROPRANOLOL HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
126729171 | 12672917 | 8 | C | TRIATEC /00116401/ | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | UNK | 0 | ||||||||||
126729171 | 12672917 | 9 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Unknown | UNK | 0 | ||||||||||
126729171 | 12672917 | 10 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | UNK | 0 | ||||||||||
126729171 | 12672917 | 11 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
126729171 | 12672917 | 12 | C | LERCAN | LERCANIDIPINE | 1 | Unknown | UNK | 0 | ||||||||||
126729171 | 12672917 | 13 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Unknown | UNK | 0 | ||||||||||
126729171 | 12672917 | 14 | C | DUROGESIC | FENTANYL | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126729171 | 12672917 | 1 | Type 2 diabetes mellitus |
126729171 | 12672917 | 3 | Type 2 diabetes mellitus |
126729171 | 12672917 | 4 | Type 2 diabetes mellitus |
126729171 | 12672917 | 5 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126729171 | 12672917 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126729171 | 12672917 | Abdominal pain | |
126729171 | 12672917 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126729171 | 12672917 | 1 | 20160309 | 0 | ||
126729171 | 12672917 | 2 | 20160311 | 20160313 | 0 | |
126729171 | 12672917 | 3 | 20160309 | 0 | ||
126729171 | 12672917 | 4 | 20160309 | 0 | ||
126729171 | 12672917 | 5 | 20160309 | 0 |